Adrienne Morgan
Tracked across 2 events · 27 articles · First seen May 29, 2026 · Last active Jul 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Adrienne Morgan, co-founder of Independent Cancer Patients' Voice and a patient who underwent chemotherapy, highlighted the urgent need for the OPTIMA trial to prevent unnecessary treatment and reduce costs.
May 29, 2026 · 21 articles
Regulatory
Impact: PG&E spokesperson who stated disconnection is a last resort and that the company would comply.
Jul 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Adrienne Morgan live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard